Viral and Host Factors in Determining Response of Relapsers with Chronic Hepatitis C to Retreatment with Interferon
- 1 January 1999
- journal article
- clinical trial
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 44 (5) , 1013-1019
- https://doi.org/10.1023/a:1026625001168
Abstract
In chronic hepatitis C the rate of relapse afteran end-of-treatment response to interferon may exceed50%. The usefulness of retreatment of relapsers withinterferon in obtaining a complete sustained...Keywords
This publication has 26 references indexed in Scilit:
- Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C: Meta-analysis of individual patient data from European centersJournal of Hepatology, 1997
- A randomized controlled trial of high-dose maintenance interferon therapy in chronic hepatitis CJournal of Medical Virology, 1997
- HCV viraemia is more important than genotype as a predictor of response to interferon in sicily (Southern Italy)Journal of Hepatology, 1996
- Efficacy of interferon alfa therapy in chronic hepatitis C patients depends primarily on hepatitis C virus RNA level.1995
- A Comparison of Three Interferon Alfa-2b Regimens for the Long-Term Treatment of Chronic Non-A, Non-B HepatitisNew England Journal of Medicine, 1995
- Combined treatment with interferon alpha‐2b and ribavirin for chronic hepatitis C in patients with a previous non‐response or non‐sustained response to interferon aloneJournal of Medical Virology, 1995
- Combination antiviral therapy with ribavirin and interferon alfa in interferon alfa relapsers and non-responders: Italian experience.1995
- Interferon-α for chronic hepatitis C: An analysis of pretreatment clinical predictors of responseHepatology, 1994
- Serum HCV RNA levels in patients with chronic hepatitis C given a second course of interferon alpha-2b treatment after relapse following initial treatment.1993
- Treatment of Chronic Hepatitis C with Recombinant Interferon AlfaNew England Journal of Medicine, 1989